Evidence map›Paper›PMID 42420694›Full record

ReviewPlant foods for human nutrition (Dordrecht, Netherlands)2026

Plant Biofactories for Vaccination: Progress in Edible Vaccine Technologies as a Sustainable Approach to Global Immunization.

Kareem A Mosa, Tushar Khare, Fathima Syed, Fazila Sirajudeen, Sarah Afzal, Zainab Dairi, Khola Younus, Varun Chauhan, Arun Kumar, Amr M Shaaban and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Plant foods for human nutrition (Dordrecht, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kareem A MosaDepartment of Applied Biology, College of Sciences, University of Sharjah, PO Box 27272, Sharjah, United Arab Emirates. kmosa@sharjah.ac.ae.
Tushar KhareDepartment of Applied Biology, College of Sciences, University of Sharjah, PO Box 27272, Sharjah, United Arab Emirates.
Fathima SyedDepartment of Applied Biology, College of Sciences, University of Sharjah, PO Box 27272, Sharjah, United Arab Emirates.
Fazila SirajudeenDepartment of Applied Biology, College of Sciences, University of Sharjah, PO Box 27272, Sharjah, United Arab Emirates.
Sarah AfzalDepartment of Applied Biology, College of Sciences, University of Sharjah, PO Box 27272, Sharjah, United Arab Emirates.
Zainab DairiDepartment of Applied Biology, College of Sciences, University of Sharjah, PO Box 27272, Sharjah, United Arab Emirates.
Khola YounusDepartment of Applied Biology, College of Sciences, University of Sharjah, PO Box 27272, Sharjah, United Arab Emirates.
Varun ChauhanCovid-19 Testing Facility, Dietetics & Nutrition Technology Division, Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, HP, 176061, India.
Arun KumarMolecular Biology & Biochemistry Lab, Fermentation and Phytofarming Technology Division, CSIR- Institute of Himalayan Bioresource Technology, Palampur, HP, 176061, India.
Amr M ShaabanFaculty of Pharmacy, Egyptian Russian University, Cairo, Egypt.
Megha KatochResearch Institute for Sciences and Engineering, University of Sharjah, Sharjah, United Arab Emirates.

Funding

Office of the Vice Chancellor for Research and Graduate Studies at the University of Sharjah 24021450161
6 · The paper itself

Abstract

Globally, the pathogen-driven enteric diseases remain a leading cause of morbidity and mortality, disproportionately affecting populations in low-income regions. While significant strides have been made in vaccine research, challenges such as high production costs, complex manufacturing processes, and inefficient distribution continue to hinder global vaccine accessibility. To overcome these challenges, plant-based edible vaccines have emerged as a promising and innovative alternative, offering advantages such as affordability, ease of administration, and reduced reliance on cold-chain infrastructure. This study presents a comprehensive overview of recent advances in the development of edible plant-derived vaccines, highlighting the strategic evolution from conventional genetic engineering to more refined and scalable biotechnological methods. In the work, various applications targeting diseases such as measles, hepatitis B, rabies, dengue, and norovirus, are discussed as well as veterinary vaccines for livestock and aquaculture. The significant progress in creating vaccines targeting prevalent human pathogens is examined and the discussion is extended to include edible vaccines developed for livestock, underscoring their role in both public and veterinary health. Furthermore, the review emphasizes the transformative potential of 'omics' technologies, such as genomics, proteomics, and metabolomics, as well as artificial intelligence in streamlining vaccine design, improving antigen expression, and accelerating development timelines. This assessment review was conducted by performing a comprehensive literature survey of peer-reviewed articles. By integrating multidisciplinary insights, the work underscores the feasibility and future prospects of edible plant vaccines as a sustainable solution to global immunization challenges, with practical applications in improving vaccine accessibility, enhancing outbreak preparedness, and supporting immunization efforts in resource-limited settings. It aims to inform and inspire continued research and collaborative innovation in this emerging field with significant implications for global public health.

Indexed as

VaccinationVaccines, EdibleAnimalsHumansPlants, Genetically ModifiedVaccine DevelopmentVaccines, EdibleAnimal vaccinesAntigensEdible vaccinesOmics and artificial intelligenceTransgenic plants

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.